/
/
/

Gujarat Kidney And Super Speciality Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
₹
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
₹34 Cr₹31 Cr₹23 Cr₹13 Cr₹15 Cr₹10 Cr₹12 Cr₹9 Cr
₹69 L₹71 L₹6 L₹9 L₹80,000₹5 L₹5 L₹5 L
₹35 Cr₹31 Cr₹23 Cr₹13 Cr₹15 Cr₹10 Cr₹12 Cr₹9 Cr
₹27 Cr₹26 Cr₹18 Cr₹9 Cr₹8 Cr₹8 Cr₹8 Cr₹5 Cr
₹9 Cr₹7 Cr₹7 Cr₹5 Cr₹9 Cr₹3 Cr₹5 Cr₹5 Cr
₹66 L₹82 L₹60 L₹28 L₹18 L₹16 L₹17 L₹16 L
₹7 Cr₹5 Cr₹5 Cr₹4 Cr₹7 Cr₹2 Cr₹4 Cr₹4 Cr
₹5 Cr₹5 Cr₹4 Cr₹3 Cr₹5 Cr₹1 Cr₹3 Cr₹3 Cr

Share Price Live Stats

Open (₹)165.38
Volume (₹)1.16 L
High (₹)167.29
Upper Circuit195.97
Low (₹)161.01
Lower Circuit130.65
Prev Close163.31
52W High (₹)209.80
Price163.59
52W Low (₹)98.36

Share Market Cap & Key Ratios Overview

M.Cap (₹)1289.09 Cr
Div. Yield (%)0.00
PE Ratio81.41
Debt to Equity0.06
Price to Book3.16
Book Value32.03
EPS (TTM)2.01
Face Value2.00
ROE (%)12.08

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
APOLLOHOSPNSE
MANIPALHOSNSE
MAXHEALTHNSE
ASTERDMNSE
FORTISNSE
NHNSE
MEDANTANSE
LALPATHLABNSE
KIMSNSE
AGARWALEYENSE
GKSLNSE
LTP
1W Low
1W High
Market cap (₹)
8459+259 (3.16%)
8100
8459
1,20,779Cr
653.5+14.7 (2.30%)
636
673.90
87,926Cr
884.75+33.6 (3.95%)
848.20
905.50
83,706Cr
673.85-5.35 (-0.79%)
668.70
690.95
59,570Cr
761.5+6.6 (0.87%)
745
772.65
58,117Cr
1834.2+119.7 (6.98%)
1680
1854
35,144Cr
1298.4-1.3 (-0.10%)
1260
1334.40
34,122Cr
1887.2-24.5 (-1.28%)
1856.50
1958
31,997Cr
720.9+18.4 (2.62%)
694.05
737.60
29,480Cr
506.2+17.5 (3.58%)
473.40
529
16,117Cr
163.59-8.28 (-4.82%)
160.84
174.28
1,289Cr

Key Highlights of Gujarat Kidney And Super Speciality Ltd’s P&L

In 2025-03-31, Gujarat Kidney And Super Speciality Ltd reported total revenue of ₹40.4Cr, compared with ₹5.48Cr in 2024-03-31, reflecting Gujarat Kidney And Super Speciality Ltd turnover.

Depreciation was ₹3.29Cr and finance costs were ₹64.63Lakh in 2025-03-31

Profit Before Tax (PBT) has been ₹12.77Cr in 2025-03-31 as compared to ₹2.27Cr in 2024-03-31.

Net Profit (PAT) was ₹9.41Cr in 2025-03-31 compared with ₹1.71Cr in 2024-03-31.

Earnings per share (EPS) were ₹1.66 in 2025-03-31, compared with ₹85.70 in 2024-03-31.